Short Interest in AGF U.S. Market Neutral Anti-Beta Fund (NYSEARCA:BTAL) Rises By 103.9%

AGF U.S. Market Neutral Anti-Beta Fund (NYSEARCA:BTALGet Free Report) was the target of a significant growth in short interest during the month of February. As of February 27th, there was short interest totaling 1,164,302 shares, a growth of 103.9% from the February 12th total of 570,879 shares. Currently, 5.0% of the company’s stock are short sold. Based on an average daily trading volume, of 976,364 shares, the days-to-cover ratio is presently 1.2 days. Based on an average daily trading volume, of 976,364 shares, the days-to-cover ratio is presently 1.2 days. Currently, 5.0% of the company’s stock are short sold.

Institutional Trading of AGF U.S. Market Neutral Anti-Beta Fund

Institutional investors have recently added to or reduced their stakes in the business. Triumph Capital Management purchased a new stake in AGF U.S. Market Neutral Anti-Beta Fund during the 3rd quarter valued at $70,000. J.Safra Asset Management Corp boosted its stake in shares of AGF U.S. Market Neutral Anti-Beta Fund by 10.0% in the 4th quarter. J.Safra Asset Management Corp now owns 8,142 shares of the company’s stock worth $117,000 after buying an additional 741 shares during the last quarter. Worth Asset Management LLC bought a new stake in shares of AGF U.S. Market Neutral Anti-Beta Fund in the fourth quarter worth $364,000. IFP Advisors Inc grew its holdings in shares of AGF U.S. Market Neutral Anti-Beta Fund by 7.4% in the third quarter. IFP Advisors Inc now owns 22,864 shares of the company’s stock worth $364,000 after acquiring an additional 1,582 shares during the period. Finally, PMV Capital Advisers LLC increased its position in AGF U.S. Market Neutral Anti-Beta Fund by 35.5% during the third quarter. PMV Capital Advisers LLC now owns 204,763 shares of the company’s stock valued at $3,260,000 after acquiring an additional 53,603 shares during the last quarter.

AGF U.S. Market Neutral Anti-Beta Fund Stock Up 0.3%

Shares of NYSEARCA BTAL traded up $0.04 during trading on Friday, reaching $14.40. The company had a trading volume of 1,360,491 shares, compared to its average volume of 855,904. AGF U.S. Market Neutral Anti-Beta Fund has a 12-month low of $13.60 and a 12-month high of $22.10. The stock has a market cap of $334.08 million, a PE ratio of 17.67 and a beta of -0.66. The business’s 50-day moving average is $14.01 and its 200 day moving average is $14.85.

AGF U.S. Market Neutral Anti-Beta Fund Dividend Announcement

The company also recently declared an annual dividend, which was paid on Friday, January 2nd. Investors of record on Tuesday, December 30th were paid a $0.3579 dividend. The ex-dividend date was Tuesday, December 30th. This represents a yield of 249.0%.

About AGF U.S. Market Neutral Anti-Beta Fund

(Get Free Report)

The AGFiQ U.S. Market Neutral Anti-Beta Fund (BTAL) is an exchange-traded fund that mostly invests in long\u002Fshort alternatives. The fund is an actively managed fund that takes long positions in low beta US stocks, offset by short positions in high beta US stocks. BTAL was launched on Sep 13, 2011 and is managed by AGF.

Read More

Receive News & Ratings for AGF U.S. Market Neutral Anti-Beta Fund Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AGF U.S. Market Neutral Anti-Beta Fund and related companies with MarketBeat.com's FREE daily email newsletter.